Susanne M. Geisen

ORCID: 0000-0002-9394-0274
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • DNA Repair Mechanisms
  • Glioma Diagnosis and Treatment
  • Carcinogens and Genotoxicity Assessment
  • Epigenetics and DNA Methylation
  • Pharmacological Effects of Natural Compounds
  • Radiation Therapy and Dosimetry
  • Social and Educational Sciences
  • Folate and B Vitamins Research
  • Radiopharmaceutical Chemistry and Applications
  • Vestibular and auditory disorders
  • Fish biology, ecology, and behavior
  • Plant tissue culture and regeneration
  • PARP inhibition in cancer therapy
  • Plant Pathogens and Fungal Diseases
  • Complementary and Alternative Medicine Studies
  • Ichthyology and Marine Biology
  • Boron Compounds in Chemistry
  • Plant Disease Management Techniques
  • Advanced Radiotherapy Techniques
  • Pharmacogenetics and Drug Metabolism
  • Amino Acid Enzymes and Metabolism

ETH Zurich
2017-2022

Department of Medical Sciences
2022

University of Bonn
2008

10.1007/s00359-008-0394-3 article EN Journal of Comparative Physiology A 2008-11-26

Temozolomide (TMZ) is a DNA-methylating agent used in cancer chemotherapy, notably for glioblastoma multiforme (GBM), where it applied as front-line drug. One of the DNA alkylation products TMZ minor lesion O6 -methylguanine (O6 MeG), which responsible nearly all genotoxic, cytotoxic, and cytostatic effects induced low-dose range relevant therapy. Here, we addressed question how many MeG adducts are required to elicit cytotoxic responses. Adduct quantification revealed that increases...

10.1158/1535-7163.mct-21-0228 article EN cc-by-nc-nd Molecular Cancer Therapeutics 2021-07-12

The O6-alkylguanosine adduct O6-carboxymethyldeoxyguanosine (O6-CMdG) has been detected at elevated levels in blood and tissue samples from colorectal cancer patients healthy volunteers after consuming red meat. diazo compound l-azaserine leads to the formation of O6-CMdG as well corresponding methyl O6-methyldeoxyguanosine (O6-MedG) cells is therefore wide use a chemical probe cellular studies concerning DNA damage mutation. However, there remain knowledge gaps basis by l-azaserine. To...

10.1021/acs.chemrestox.0c00471 article EN Chemical Research in Toxicology 2021-06-01

The protein O6-methylguanine-DNA methyltransferase (MGMT) is able to repair the mutagenic O6-methylguanine (O6-MeG) adduct back guanine. In this context, it may protect against colorectal cancer formation associated with N-nitroso compounds. Such compounds be endogenously formed by nitrosylation of amino acids, which can give rise O6-MeG and O6-carboxymethylguanine (O6-CMG) adducts. It well established that repaired MGMT. However, up now, whether O6-CMG enzyme remains unresolved. Therefore,...

10.1093/carcin/bgab049 article EN Carcinogenesis 2021-06-09

Distinct cellular DNA damage repair pathways maintain the structural integrity of and protect it from mutagenic effects genotoxic exposures processes. The occurrence O6-carboxymethylguanine (O6-CMG) has been linked to meat consumption hypothesized contribute development colorectal cancer. However, fate O6-CMG is poorly characterized there contradictory data in literature as how may cells mutagenicity. To better address detect remove O6-CMG, we evaluated role two counteracting accumulation...

10.1016/j.dnarep.2021.103262 article EN cc-by-nc-nd DNA repair 2021-12-29
Coming Soon ...